Therapeutic benefit of treatment with anti-thymocyte globulin and latent TGF-beta1 in the MRL/lpr lupus mouse model.
Kaplan J; Woodworth L; Smith K; Coco J; Vitsky A; McPherson J; Lupus, 2008, vol. 17, issue 9, p 822, ISSN 09612033. ISBN 09612033.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef